Corium International Stock Price, News & Analysis (NASDAQ:CORI)

$13.24 +0.25 (+1.92 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$13.24
Today's Range$12.67 - $13.35
52-Week Range$3.44 - $13.93
Volume146,580 shs
Average Volume147,884 shs
Market Capitalization$469.25 million
P/E Ratio-8.38
Dividend YieldN/A
Beta1.59

About Corium International (NASDAQ:CORI)

Corium International logoCorium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the Company had multiple programs in preclinical and clinical development focused primarily on the treatment of neurological disorders, with two lead programs in Alzheimer's disease. The Company has two transdermal platforms: Corplex for small molecules and MicroCor, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins. Its late-stage pipeline includes a contraceptive patch, which has completed Phase III trials, and additional transdermal products that are being developed with other partners. Its products include Clonidine TDS, Fentanyl TDS and Crest Whitestrips. Its pipeline products include Twirla, Corplex Donepezil and Corplex Memantine, Donepezil, Corplex Ropinerole, MicroCor hPTH(1-34) and Motion Sickness Patch.

Receive CORI News and Ratings via Email

Sign-up to receive the latest news and ratings for CORI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CORI
CUSIPN/A
Phone650-298-8255

Debt

Debt-to-Equity Ratio5.91%
Current Ratio1.40%
Quick Ratio1.34%

Price-To-Earnings

Trailing P/E Ratio-8.37969379940633
Forward P/E Ratio-9.26
P/E GrowthN/A

Sales & Book Value

Annual Sales$31.86 million
Price / Sales15.01
Cash FlowN/A
Price / CashN/A
Book Value$0.12 per share
Price / Book110.33

Profitability

Trailing EPS($1.58)
Net Income$-47,790,000.00
Net Margins-148.07%
Return on Equity-403.15%
Return on Assets-62.88%

Miscellaneous

Employees213
Outstanding Shares36,120,000

Corium International (NASDAQ:CORI) Frequently Asked Questions

What is Corium International's stock symbol?

Corium International trades on the NASDAQ under the ticker symbol "CORI."

How were Corium International's earnings last quarter?

Corium International Inc (NASDAQ:CORI) posted its earnings results on Thursday, February, 8th. The biopharmaceutical company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.43) by $0.06. The biopharmaceutical company earned $9.32 million during the quarter, compared to analysts' expectations of $7.48 million. Corium International had a negative net margin of 148.07% and a negative return on equity of 403.15%. View Corium International's Earnings History.

Where is Corium International's stock going? Where will Corium International's stock price be in 2018?

6 analysts have issued 1 year target prices for Corium International's stock. Their predictions range from $10.00 to $14.00. On average, they anticipate Corium International's share price to reach $13.00 in the next twelve months. View Analyst Ratings for Corium International.

What are Wall Street analysts saying about Corium International stock?

Here are some recent quotes from research analysts about Corium International stock:

  • 1. According to Zacks Investment Research, "Corium International, Inc. is a commercial-stage biopharmaceutical company. It is focused on the development, manufacture and commercialization of specialty pharmaceutical products that leverage advanced technologies in transdermal and transmucosal delivery systems. Corium has developed six marketed products in the prescription drug and consumer markets: Clonidine Transdermal Delivery System for hypertension, Fentanyl TDS for chronic pain and four Crest Advanced Seal Whitestrips products. The company has two proprietary transdermal technology platforms with applications in multiple drug categories and indications: Corplex(TM) and MicroCor(R). Corium International, Inc. is headquartered in Menlo Park, California. " (1/22/2018)
  • 2. Cantor Fitzgerald analysts commented, "Changes to the CORI model. We updated our CORI model Twirla segment to reflect changes made to AGRX, shifting our assumed Twirla launch to 2Q19 and increasing our pTS to 50% from 75%. We are maintaining our peak Twirla sales assumptions of $230 million in 2024. We have always assumed CORI captures a lower margin on Twirla sales in keeping with their manufacturing role that reduces the incremental value of the program relative to other proprietary projects. These changes did not alter our price target of $14." (12/22/2017)

Who are some of Corium International's key competitors?

Who are Corium International's key executives?

Corium International's management team includes the folowing people:

  • David L. Greenwood, Chairman of the Board (Age 64)
  • Peter D. Staple, President, Chief Executive Officer, Director (Age 65)
  • Robert S. Breuil, Chief Financial Officer (Age 51)
  • Parminder Singh Ph.D., Chief Technology Officer, Vice President - Research & Development (Age 52)
  • Joseph J. Sarret M.D. J.D., Chief Business Officer (Age 48)
  • Robert W. Thomas, Lead Independent Director (Age 54)
  • Eric H. Bjerkholt, Independent Director (Age 57)
  • Bhaskar Chaudhuri Ph.D., Independent Director (Age 62)
  • Ronald W. Eastman, Independent Director
  • Phyllis I. Gardner M.D., Independent Director (Age 65)

Who owns Corium International stock?

Corium International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Broadfin Capital LLC (9.50%), AWM Investment Company Inc. (6.28%), RTW Investments LP (4.71%), BlackRock Inc. (4.65%), Opaleye Management Inc. (2.93%) and Tamarack Advisers LP (2.80%). Company insiders that own Corium International stock include David Greenwood, Eric Bjerkholt, Healthcare Master Fun Broadfin, Joseph J Sarret, Life Sciences Maste Perceptive, Parminder Singh, Perceptive Advisors Llc and Timothy D Sweemer. View Institutional Ownership Trends for Corium International.

Who sold Corium International stock? Who is selling Corium International stock?

Corium International's stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, Needham Investment Management LLC, Essex Investment Management Co. LLC, Royce & Associates LP, Iguana Healthcare Management LLC, AWM Investment Company Inc., EAM Investors LLC and TIAA CREF Investment Management LLC. Company insiders that have sold Corium International company stock in the last year include Healthcare Master Fun Broadfin, Joseph J Sarret, Parminder Singh and Timothy D Sweemer. View Insider Buying and Selling for Corium International.

Who bought Corium International stock? Who is buying Corium International stock?

Corium International's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Emory University, Opaleye Management Inc., Millennium Management LLC, Candriam Luxembourg S.C.A., Tamarack Advisers LP, Two Sigma Investments LP and Two Sigma Advisers LP. Company insiders that have bought Corium International stock in the last two years include David Greenwood, Eric Bjerkholt, Life Sciences Maste Perceptive and Perceptive Advisors Llc. View Insider Buying and Selling for Corium International.

How do I buy Corium International stock?

Shares of Corium International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corium International's stock price today?

One share of Corium International stock can currently be purchased for approximately $13.24.

How big of a company is Corium International?

Corium International has a market capitalization of $469.25 million and generates $31.86 million in revenue each year. The biopharmaceutical company earns $-47,790,000.00 in net income (profit) each year or ($1.58) on an earnings per share basis. Corium International employs 213 workers across the globe.

How can I contact Corium International?

Corium International's mailing address is 235 CONSTITUTION DRIVE, MENLO PARK CA, 94025. The biopharmaceutical company can be reached via phone at 650-298-8255 or via email at [email protected]


MarketBeat Community Rating for Corium International (CORI)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  242 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  404
MarketBeat's community ratings are surveys of what our community members think about Corium International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Corium International (NASDAQ:CORI) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$13.17$12.33
Price Target Upside: 8.70% upside30.65% upside15.19% upside57.92% upside

Corium International (NASDAQ:CORI) Consensus Price Target History

Price Target History for Corium International (NASDAQ:CORI)

Corium International (NASDAQ:CORI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018HC WainwrightSet Price TargetBuy$14.00LowView Rating Details
12/26/2017Needham & Company LLCLower Price TargetBuy -> Buy$16.00 -> $14.00HighView Rating Details
12/22/2017Cantor FitzgeraldReiterated RatingBuy$14.00LowView Rating Details
10/29/2017Jefferies GroupSet Price TargetBuy$10.00N/AView Rating Details
7/7/2017WBB SecuritiesUpgradeBuy$13.00LowView Rating Details
4/18/2017FBR & CoReiterated RatingOutperform -> Outperform$12.00 -> $13.00LowView Rating Details
1/4/2017Leerink SwannReiterated RatingBuyN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Corium International (NASDAQ:CORI) Earnings History and Estimates Chart

Earnings by Quarter for Corium International (NASDAQ:CORI)

Corium International (NASDAQ CORI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018Q1 2018($0.43)($0.37)$7.48 million$9.32 millionViewN/AView Earnings Details
11/16/2017Q4 2017($0.43)($0.36)$9.57 million$9.44 millionViewN/AView Earnings Details
8/3/2017Q3 2017($0.30)($0.43)$8.71 million$8.11 millionViewListenView Earnings Details
5/11/2017Q2 2017($0.37)($0.42)$6.05 million$7.35 millionViewN/AView Earnings Details
2/13/2017Q1 2017($0.42)($0.46)$8.07 million$7.00 millionViewN/AView Earnings Details
11/21/2016Q4 2016($0.39)($0.42)$9.08 million$7.92 millionViewN/AView Earnings Details
8/4/2016Q3($0.42)($0.34)$8.38 million$10.61 millionViewN/AView Earnings Details
5/10/2016Q2($0.37)($0.47)$8.64 million$6.96 millionViewListenView Earnings Details
2/8/2016Q1($0.35)($0.42)$8.93 million$7.54 millionViewN/AView Earnings Details
11/12/2015Q4($0.45)($0.42)$9.47 million$9.27 millionViewListenView Earnings Details
7/29/2015Q3($0.37)($0.33)$10.45 million$10.60 millionViewListenView Earnings Details
5/7/2015Q2 2015($0.35)($0.40)$9.73 million$11.29 millionViewN/AView Earnings Details
2/10/2015Q115($0.29)($0.37)$10.42 million$9.77 millionViewN/AView Earnings Details
11/17/2014Q4 2014($0.32)($0.51)$10.26 million$11.07 millionViewN/AView Earnings Details
8/12/2014Q3 2014($0.17)($0.28)$12.22 million$10.18 millionViewN/AView Earnings Details
5/13/2014Q2 2014($0.18)($0.24)$10.58 million$10.72 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Corium International (NASDAQ:CORI) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.43 EPS
Next Year EPS Consensus Estimate: $-1.28 EPS

Dividends

Dividend History for Corium International (NASDAQ:CORI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Corium International (NASDAQ CORI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 30.80%
Institutional Ownership Percentage: 87.29%
Insider Trades by Quarter for Corium International (NASDAQ:CORI)
Institutional Ownership by Quarter for Corium International (NASDAQ:CORI)

Corium International (NASDAQ CORI) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/18/2018Life Sciences Maste PerceptiveMajor ShareholderBuy510,000$12.54$6,395,400.00View SEC Filing  
1/16/2018Perceptive Advisors LlcMajor ShareholderBuy50,350$11.83$595,640.50View SEC Filing  
11/17/2017Healthcare Master Fun BroadfinMajor ShareholderSell500,000$10.96$5,480,000.00View SEC Filing  
11/2/2017Healthcare Master Fun BroadfinMajor ShareholderSell150,000$11.05$1,657,500.00View SEC Filing  
10/4/2017Healthcare Master Fun BroadfinMajor ShareholderSell218,100$11.01$2,401,281.00View SEC Filing  
8/22/2017Parminder SinghInsiderSell30,415$7.59$230,849.8530,762View SEC Filing  
8/17/2017Parminder SinghInsiderSell32,000$7.61$243,520.00View SEC Filing  
8/17/2017Timothy D. SweemerCAOSell12,012$7.62$91,531.44View SEC Filing  
8/16/2017Timothy D. SweemerCAOSell15,488$7.82$121,116.16View SEC Filing  
7/20/2017Joseph J. SarretInsiderSell2,038$8.95$18,240.10View SEC Filing  
6/30/2017Life Sciences Maste PerceptiveMajor ShareholderBuy301,004$7.71$2,320,740.84View SEC Filing  
5/25/2017Perceptive Advisors LlcMajor ShareholderBuy1,902,400$6.25$11,890,000.00View SEC Filing  
5/19/2016Eric BjerkholtDirectorBuy24,500$3.64$89,180.00View SEC Filing  
5/12/2016David GreenwoodDirectorBuy3,000$3.58$10,740.003,000View SEC Filing  
2/25/2015Peter D StapleCEOBuy3,600$6.99$25,164.00View SEC Filing  
11/24/2014Robert S BreuilCFOBuy4,600$5.38$24,748.00View SEC Filing  
11/21/2014Peter D StapleCEOBuy9,000$5.34$48,060.00View SEC Filing  
8/27/2014Peter D StapleCEOBuy2,578$6.10$15,725.80View SEC Filing  
5/30/2014Peter D StapleCEOBuy7,200$7.04$50,688.00View SEC Filing  
4/8/2014Woodlands Health Venture EssexMajor ShareholderBuy400,000$8.00$3,200,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Corium International (NASDAQ CORI) News Headlines

Source:
DateHeadline
Zacks: Brokerages Anticipate Corium International Inc (CORI) Will Post Earnings of -$0.41 Per ShareZacks: Brokerages Anticipate Corium International Inc (CORI) Will Post Earnings of -$0.41 Per Share
www.americanbankingnews.com - February 24 at 8:06 AM
Corium International Inc (CORI) Given Average Rating of "Buy" by BrokeragesCorium International Inc (CORI) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - February 20 at 5:32 PM
FY2018 EPS Estimates for Corium International Inc Raised by Cantor Fitzgerald (CORI)FY2018 EPS Estimates for Corium International Inc Raised by Cantor Fitzgerald (CORI)
www.americanbankingnews.com - February 14 at 11:24 AM
Corium International (CORI) PT Set at $14.00 by HC WainwrightCorium International (CORI) PT Set at $14.00 by HC Wainwright
www.americanbankingnews.com - February 10 at 4:44 PM
Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate HighlightsCorium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights
finance.yahoo.com - February 8 at 4:42 PM
Corium International Inc (CORI) Expected to Announce Earnings of -$0.43 Per ShareCorium International Inc (CORI) Expected to Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - February 7 at 9:52 AM
Corium to Present at Upcoming Healthcare Investor ConferencesCorium to Present at Upcoming Healthcare Investor Conferences
finance.yahoo.com - February 6 at 8:48 AM
Tetraphase Pharmaceuticals (TTPH) vs. Corium International (CORI) Financial AnalysisTetraphase Pharmaceuticals (TTPH) vs. Corium International (CORI) Financial Analysis
www.americanbankingnews.com - February 5 at 1:39 PM
Corium International (CORI) Lowered to "Hold" at BidaskClubCorium International (CORI) Lowered to "Hold" at BidaskClub
www.americanbankingnews.com - February 3 at 11:58 AM
Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018Corium to Report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018
finance.yahoo.com - February 1 at 4:46 PM
Head to Head Review: Corium International (CORI) and Novo Nordisk A/S (NVO)Head to Head Review: Corium International (CORI) and Novo Nordisk A/S (NVO)
www.americanbankingnews.com - January 31 at 9:12 PM
3 Hot Insider Biotech Stocks You Need to Know3 Hot Insider Biotech Stocks You Need to Know
www.nasdaq.com - January 29 at 8:54 AM
Corium International Inc (CORI) Receives Average Rating of "Buy" from BrokeragesCorium International Inc (CORI) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 26 at 5:38 PM
Corium International (CORI) Raised to Hold at Zacks Investment ResearchCorium International (CORI) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - January 22 at 9:18 PM
Zacks: Brokerages Anticipate Corium International Inc (CORI) to Announce -$0.43 Earnings Per ShareZacks: Brokerages Anticipate Corium International Inc (CORI) to Announce -$0.43 Earnings Per Share
www.americanbankingnews.com - January 21 at 11:24 AM
Corium International Inc (CORI) Major Shareholder Perceptive Advisors Llc Acquires 50,350 SharesCorium International Inc (CORI) Major Shareholder Perceptive Advisors Llc Acquires 50,350 Shares
www.americanbankingnews.com - January 18 at 7:00 PM
Corium International Inc (CORI) Major Shareholder Life Sciences Maste Perceptive Purchases 510,000 SharesCorium International Inc (CORI) Major Shareholder Life Sciences Maste Perceptive Purchases 510,000 Shares
www.americanbankingnews.com - January 18 at 6:34 PM
FY2018 EPS Estimates for Corium International Inc (CORI) Cut by Cantor FitzgeraldFY2018 EPS Estimates for Corium International Inc (CORI) Cut by Cantor Fitzgerald
www.americanbankingnews.com - January 18 at 4:36 PM
Corium International Inc (CORI) Expected to Post Quarterly Sales of $7.48 MillionCorium International Inc (CORI) Expected to Post Quarterly Sales of $7.48 Million
www.americanbankingnews.com - January 6 at 4:14 AM
Corium International Inc (CORI) Expected to Post FY2019 Earnings of ($0.94) Per ShareCorium International Inc (CORI) Expected to Post FY2019 Earnings of ($0.94) Per Share
www.americanbankingnews.com - January 4 at 10:42 PM
Head-To-Head Analysis: Corium International (CORI) versus Its PeersHead-To-Head Analysis: Corium International (CORI) versus Its Peers
www.americanbankingnews.com - January 3 at 5:34 PM
Critical Comparison: Corium International (CORI) & Its CompetitorsCritical Comparison: Corium International (CORI) & Its Competitors
www.americanbankingnews.com - January 2 at 5:12 PM
Corium International Inc (CORI) Given Consensus Rating of "Buy" by AnalystsCorium International Inc (CORI) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - January 1 at 5:38 PM
Corium International, Inc. :CORI-US: Earnings Analysis: Q4, 2017 By the Numbers : January 1, 2018Corium International, Inc. :CORI-US: Earnings Analysis: Q4, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 9:47 AM
Critical Contrast: Corium International (CORI) & Its RivalsCritical Contrast: Corium International (CORI) & Its Rivals
www.americanbankingnews.com - January 1 at 3:28 AM
Corium International (CORI) versus Its Rivals Head to Head AnalysisCorium International (CORI) versus Its Rivals Head to Head Analysis
www.americanbankingnews.com - January 1 at 1:30 AM
Equities Analysts Offer Predictions for Corium International Incs FY2018 Earnings (CORI)Equities Analysts Offer Predictions for Corium International Inc's FY2018 Earnings (CORI)
www.americanbankingnews.com - December 30 at 9:32 PM
Corium International (CORI) Downgraded to Sell at Zacks Investment ResearchCorium International (CORI) Downgraded to Sell at Zacks Investment Research
www.americanbankingnews.com - December 29 at 9:26 PM
Free Research Report as Coriums Revenue Grew 19.2%Free Research Report as Corium's Revenue Grew 19.2%
finance.yahoo.com - December 29 at 4:56 PM
Corium International Inc (CORI) Files 10-K for the Fiscal Year Ended on September 30, 2017Corium International Inc (CORI) Files 10-K for the Fiscal Year Ended on September 30, 2017
finance.yahoo.com - December 29 at 9:06 AM
Head to Head Review: Corium International (CORI) versus Its RivalsHead to Head Review: Corium International (CORI) versus Its Rivals
www.americanbankingnews.com - December 28 at 7:34 PM
What Should We Expect From Corium International Inc’s (NASDAQ:CORI) Earnings In Next 12 Months?What Should We Expect From Corium International Inc’s (NASDAQ:CORI) Earnings In Next 12 Months?
finance.yahoo.com - December 27 at 5:59 PM
Analyst Remains Confident In Corium Despite Partners Bad FDA NewsAnalyst Remains Confident In Corium Despite Partner's Bad FDA News
feeds.benzinga.com - December 27 at 12:41 PM
Needham & Company LLC Lowers Corium International (CORI) Price Target to $14.00Needham & Company LLC Lowers Corium International (CORI) Price Target to $14.00
www.americanbankingnews.com - December 26 at 8:34 AM
Corium International, Inc. breached its 50 day moving average in a Bearish Manner : CORI-US : December 25, 2017Corium International, Inc. breached its 50 day moving average in a Bearish Manner : CORI-US : December 25, 2017
finance.yahoo.com - December 25 at 6:42 PM
Critical Review: Corium International (CORI) and The CompetitionCritical Review: Corium International (CORI) and The Competition
www.americanbankingnews.com - December 24 at 5:15 AM
Financial Contrast: Corium International (CORI) & Its PeersFinancial Contrast: Corium International (CORI) & Its Peers
www.americanbankingnews.com - December 23 at 11:40 AM
Cantor Fitzgerald Reiterates Buy Rating for Corium International (CORI)Cantor Fitzgerald Reiterates Buy Rating for Corium International (CORI)
www.americanbankingnews.com - December 22 at 4:42 PM
Zacks: Analysts Anticipate Corium International Inc (CORI) Will Announce Quarterly Sales of $8.48 MillionZacks: Analysts Anticipate Corium International Inc (CORI) Will Announce Quarterly Sales of $8.48 Million
www.americanbankingnews.com - December 21 at 6:14 PM
Corium International (CORI) & Its Peers Financial ContrastCorium International (CORI) & Its Peers Financial Contrast
www.americanbankingnews.com - December 20 at 1:08 AM
Corium International (CORI) versus The Competition Financial ReviewCorium International (CORI) versus The Competition Financial Review
www.americanbankingnews.com - December 19 at 5:22 PM
Corium International Inc (CORI) Expected to Post Earnings of -$0.42 Per ShareCorium International Inc (CORI) Expected to Post Earnings of -$0.42 Per Share
www.americanbankingnews.com - December 19 at 1:26 AM
Corium to Join NASDAQ Biotechnology IndexCorium to Join NASDAQ Biotechnology Index
finance.yahoo.com - December 12 at 10:18 AM
Financial Analysis: Corium International (CORI) and Its PeersFinancial Analysis: Corium International (CORI) and Its Peers
www.americanbankingnews.com - December 11 at 6:26 PM
Corium International, Inc. (CORI) Given Consensus Rating of "Buy" by BrokeragesCorium International, Inc. (CORI) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - December 7 at 5:54 PM
Corium International (CORI) & The Competition Critical ReviewCorium International (CORI) & The Competition Critical Review
www.americanbankingnews.com - December 6 at 2:46 PM
 Brokerages Expect Corium International, Inc. (CORI) to Announce -$0.42 EPS Brokerages Expect Corium International, Inc. (CORI) to Announce -$0.42 EPS
www.americanbankingnews.com - November 30 at 11:24 PM
Corium International (CORI) Upgraded to "Hold" by Zacks Investment ResearchCorium International (CORI) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - November 28 at 9:20 PM
FY2018 EPS Estimates for Corium International, Inc. Cut by Analyst (CORI)FY2018 EPS Estimates for Corium International, Inc. Cut by Analyst (CORI)
www.americanbankingnews.com - November 22 at 2:24 PM
Corium International, Inc. (CORI) to Post FY2022 Earnings of $0.86 Per Share, Jefferies Group ForecastsCorium International, Inc. (CORI) to Post FY2022 Earnings of $0.86 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - November 20 at 2:30 PM

SEC Filings

Corium International (NASDAQ:CORI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Corium International (NASDAQ:CORI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Corium International (NASDAQ CORI) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.